INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42m ago
HOUSE PTR2m ago
SEC 13F2m ago
ROBINHOOD CHAIN2m ago
Public company

CMPSCOMPASS Pathways plc

CIK 0001816590

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score21
Connections9with evidence

CMPS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MR
McQuade RobertDirector
CMPSCOMPASS Pathways plc
Grant or award
A—
21.1K sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    AVENUE SOLUTIONSLDA RR 2026 second quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    McQuade RobertDirector · May 29, 2026
9
TK
Tregoning KathleenDirector
CMPSCOMPASS Pathways plc
Grant or award
A
—
41.1K sh
May 27, 2026
May 29, 2026
traded May 27, 2026
+2d
SEC FORM 4

Evidence

9
KD
Karydas DaphneDirector
CMPSCOMPASS Pathways plc
Grant or award
A—
21.1K sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

21
NK
Nath KabirDirector, Chief Executive Officer
CMPSCOMPASS Pathways plc
Grant or award
A—
175.0K sh
Mar 26, 2026Mar 27, 2026
traded Mar 26, 2026
+1dSEC FORM 4

Evidence

9
NK
Nath KabirDirector, Chief Executive Officer
CMPSCOMPASS Pathways plc
Grant or award
A—
367.8K sh
Mar 26, 2026Mar 27, 2026
traded Mar 26, 2026
+1dSEC FORM 4

Evidence

9
GG
Goodwin GuyChief Medical Officer
CMPSCOMPASS Pathways plc
Grant or award
A—
55.0K sh
Mar 26, 2026Mar 27, 2026
traded Mar 26, 2026
+1dSEC FORM 4

Evidence

9
GG
Goodwin GuyChief Medical Officer
CMPSCOMPASS Pathways plc
Grant or award
A—
115.6K sh
Mar 26, 2026Mar 27, 2026
traded Mar 26, 2026
+1dSEC FORM 4

Evidence

21
LT
Loxam TeriChief Financial Officer
CMPSCOMPASS Pathways plc
Grant or award
A—
75.0K sh
Mar 26, 2026Mar 27, 2026
traded Mar 26, 2026
+1dSEC FORM 4

Evidence

9
LT
Loxam TeriChief Financial Officer
CMPSCOMPASS Pathways plc
Grant or award
A—
157.6K sh
Mar 26, 2026Mar 27, 2026
traded Mar 26, 2026
+1dSEC FORM 4

Evidence

16
NK
Nath KabirDirector, Chief Executive Officer
CMPSCOMPASS Pathways plc
Tax withholding
F$90K
13.1K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Tregoning KathleenDirector · May 29, 2026
  • ← Insider ofevidence
    Karydas DaphneDirector · May 29, 2026
  • ← Insider ofevidence
    Loxam TeriChief Financial Officer · Mar 27, 2026
  • ← Insider ofevidence
    Goodwin GuyChief Medical Officer · Mar 27, 2026
  • ← Insider ofevidence
    Nath KabirDirector, Chief Executive Officer · Mar 13, 2026

    • Lobbying

    $240K reported · de-duplicated
    2026 Q2 $130K in-house2026 Q1 $110K in-house
    • In-house report$130K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations
    • AVENUE SOLUTIONS$30K2026 Q2 · posted Aug 26, 2026 · Health issues
    • TODD STRATEGY GROUP$80K2026 Q1 · posted Aug 26, 2026 · Health issues
    • AVENUE SOLUTIONS—2026 Q2 · posted Aug 26, 2026 · Health issues
    • In-house report$110K2026 Q1 · posted Aug 26, 2026 · Budget/appropriations
    • TODD STRATEGY GROUP$80K2026 Q2 · posted Aug 26, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.